{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T15:00:29Z","timestamp":1791212429102,"version":"4.1.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Surgery"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1016\/j.surg.2014.11.006","type":"journal-article","created":{"date-parts":[[2015,2,12]],"date-time":"2015-02-12T05:52:37Z","timestamp":1423720357000},"page":"666-675","source":"Crossref","is-referenced-by-count":78,"title":["Is there a role for systematic hepatic pedicle lymphadenectomy in intrahepatic cholangiocarcinoma? A\u00a0review of 17 years of experience in a\u00a0tertiary institution"],"prefix":"10.1016","volume":"157","author":[{"given":"Dong Hun","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong Wook","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seong Ho","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin Seok","family":"Heo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfred Wei-Chieh","family":"Kow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.surg.2014.11.006_bib1","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.surg.2008.11.010","article-title":"Therapeutic value of lymph node dissection during hepatectomy in patients with intrahepatic cholangiocellular carcinoma with negative lymph node involvement","volume":"145","author":"Shimada","year":"2009","journal-title":"Surgery"},{"key":"10.1016\/j.surg.2014.11.006_bib2","doi-asserted-by":"crossref","first-page":"3048","DOI":"10.1245\/s10434-009-0631-1","article-title":"The prognosis and survival outcome of intrahepatic cholangiocarcinoma following surgical resection: association of lymph node metastasis and lymph node dissection with survival","volume":"16","author":"Choi","year":"2009","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.surg.2014.11.006_bib3","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1007\/s00535-006-1877-z","article-title":"Predictive factors for intrahepatic cholangiocarcinoma recurrence in the liver following surgery","volume":"41","author":"Miwa","year":"2006","journal-title":"J\u00a0Gastroenterol"},{"key":"10.1016\/j.surg.2014.11.006_bib4","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1097\/SLA.0b013e318176c4d3","article-title":"Intrahepatic cholangiocarcinoma: rising frequency, improved survival, and determinants of outcome after resection","volume":"248","author":"Endo","year":"2008","journal-title":"Ann Surg"},{"key":"10.1016\/j.surg.2014.11.006_bib5","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/S0140-6736(05)63789-0","article-title":"Increase in primary liver cancer in the UK, 1979-94","volume":"350","author":"Taylor-Robinson","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.surg.2014.11.006_bib6","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1007\/s00268-001-0291-1","article-title":"Clinicopathological prognostic factors and impact of surgical treatment of mass-forming intrahepatic cholangiocarcinoma","volume":"26","author":"Suzuki","year":"2002","journal-title":"World J Surg"},{"key":"10.1016\/j.surg.2014.11.006_bib7","doi-asserted-by":"crossref","first-page":"5976","DOI":"10.3748\/wjg.15.5976","article-title":"Clinicopathological and prognostic analysis of 429 patients with intrahepatic cholangiocarcinoma","volume":"15","author":"Shen","year":"2009","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.surg.2014.11.006_bib8","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1245\/s10434-010-0929-z","article-title":"Clinicopathological prognostic factors after hepatectomy for patients with mass-forming type intrahepatic cholangiocarcinoma: relevance of the lymphatic invasion index","volume":"17","author":"Shirabe","year":"2010","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.surg.2014.11.006_bib9","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1007\/s00268-005-7761-9","article-title":"Number of lymph node metastases is a significant prognostic factor in intrahepatic cholangiocarcinoma","volume":"29","author":"Nakagawa","year":"2005","journal-title":"World J Surg"},{"key":"10.1016\/j.surg.2014.11.006_bib10","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1001\/archsurg.1995.01430100051011","article-title":"Intrahepatic cholangiocarcinoma. Results of aggressive surgical management","volume":"130","author":"Cherqui","year":"1995","journal-title":"Arch Surg"},{"key":"10.1016\/j.surg.2014.11.006_bib11","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s005340050093","article-title":"Extended resection for intrahepatic cholangiocarcinoma in Japan","volume":"6","author":"Yamamoto","year":"1999","journal-title":"J\u00a0Hepatobiliary Pancreat Surg"},{"key":"10.1016\/j.surg.2014.11.006_bib12","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1097\/01.sla.0000149426.08580.a1","article-title":"Extended hepatectomy for intrahepatic cholangiocellular carcinoma (ICC): when is it worthwhile? Single center experience with 27 resections in 50 patients over a 5-year period","volume":"241","author":"Lang","year":"2005","journal-title":"Ann Surg"},{"key":"10.1016\/j.surg.2014.11.006_bib13","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1097\/PPO.0b013e31819e3312","article-title":"Retrospective analysis of histopathologic prognostic factors after hepatectomy for intrahepatic cholangiocarcinoma","volume":"15","author":"Jiang","year":"2009","journal-title":"Cancer J"},{"key":"10.1016\/j.surg.2014.11.006_bib14","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1002\/bjs.6654","article-title":"Lymph node ratio after curative surgery for intrahepatic cholangiocarcinoma","volume":"96","author":"Tamandl","year":"2009","journal-title":"Br J Surg"},{"key":"10.1016\/j.surg.2014.11.006_bib15","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s00534-007-1315-5","article-title":"Indications for surgical treatment of intrahepatic cholangiocarcinoma with lymph node metastases","volume":"15","author":"Uenishi","year":"2008","journal-title":"J\u00a0Hepatobiliary Pancreat Surg"},{"key":"10.1016\/j.surg.2014.11.006_bib16","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1046\/j.0007-1323.2001.01879.x","article-title":"Value of lymph node dissection during resection of intrahepatic cholangiocarcinoma","volume":"88","author":"Shimada","year":"2001","journal-title":"Br J Surg"},{"key":"10.1016\/j.surg.2014.11.006_bib17","first-page":"2353","article-title":"The impact of surgical treatment and poor prognostic factors for patients with intrahepatic cholangiocarcinoma: retrospective analysis of 60 patients","volume":"28","author":"Yamashita","year":"2008","journal-title":"Anticancer Res"},{"key":"10.1016\/j.surg.2014.11.006_bib18","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1002\/cncr.25712","article-title":"AJCC 7th edition of TNM staging accurately discriminates outcomes of patients with resectable intrahepatic cholangiocarcinoma: by the AFC-IHCC-2009 study group","volume":"117","author":"Farges","year":"2011","journal-title":"Cancer"},{"key":"10.1016\/j.surg.2014.11.006_bib19","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1245\/s10434-008-0081-1","article-title":"Influence of hepatic resection margin on recurrence and survival in intrahepatic cholangiocarcinoma","volume":"15","author":"Tamandl","year":"2008","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.surg.2014.11.006_bib20","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1111\/j.1440-1746.2007.05040.x","article-title":"What prognostic factors are important for resected intrahepatic cholangiocarcinoma?","volume":"23","author":"Paik","year":"2008","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.surg.2014.11.006_bib21","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1007\/s00534-002-0842-3","article-title":"Long-term survival and prognostic factors in the surgical treatment for intrahepatic cholangiocarcinoma","volume":"10","author":"Morimoto","year":"2003","journal-title":"J\u00a0Hepatobiliary Pancreat Surg"},{"key":"10.1016\/j.surg.2014.11.006_bib22","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1046\/j.1365-2168.2002.02268.x","article-title":"Results of surgical treatment for intrahepatic cholangiocarcinoma and clinicopathological factors influencing survival","volume":"89","author":"Ohtsuka","year":"2002","journal-title":"Br J Surg"},{"key":"10.1016\/j.surg.2014.11.006_bib23","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1007\/s00268-005-7763-7","article-title":"Clinicopathological factors predicting long-term overall survival after hepatectomy for peripheral cholangiocarcinoma","volume":"29","author":"Jan","year":"2005","journal-title":"World J Surg"},{"key":"10.1016\/j.surg.2014.11.006_bib24","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/S1072-7515(01)01016-X","article-title":"Intrahepatic cholangiocarcinoma: resectability, recurrence pattern, and outcomes","volume":"193","author":"Weber","year":"2001","journal-title":"J\u00a0Am Coll Surg"},{"key":"10.1016\/j.surg.2014.11.006_bib25","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s00534-010-0349-2","article-title":"Impact of nodal involvement on surgical outcomes of intrahepatic cholangiocarcinoma: a multicenter analysis by the Study Group for Hepatic Surgery of the Japanese Society of Hepato-Biliary-Pancreatic Surgery","volume":"18","author":"Uchiyama","year":"2011","journal-title":"J\u00a0Hepatobiliary Pancreat Sci"},{"key":"10.1016\/j.surg.2014.11.006_bib26","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1002\/jso.21201","article-title":"The evolution of lymph node assessment in breast cancer","volume":"99","author":"Quan","year":"2009","journal-title":"J\u00a0Surg Oncol"},{"key":"10.1016\/j.surg.2014.11.006_bib27","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s10434-999-0109-1","article-title":"The impact of prophylactic axillary node dissection on breast cancer survival\u2013a Bayesian meta-analysis","volume":"6","author":"Orr","year":"1999","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.surg.2014.11.006_bib28","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1200\/JCO.2004.12.108","article-title":"Axillary treatment in conservative management of operable breast cancer: dissection or radiotherapy? Results of a randomized study with 15 years of follow-up","volume":"22","author":"Louis-Sylvestre","year":"2004","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.surg.2014.11.006_bib29","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.1200\/JCO.2004.10.184","article-title":"Gastric cancer surgery: morbidity and mortality results from a prospective randomized controlled trial comparing D2 and extended para-aortic lymphadenectomy\u2013Japan Clinical Oncology Group study 9501","volume":"22","author":"Sano","year":"2004","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.surg.2014.11.006_bib30","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1002\/jso.21646","article-title":"The extent of lymph node dissection for gastric cancer: a critical appraisal","volume":"102","author":"de Bree","year":"2010","journal-title":"J\u00a0Surg Oncol"},{"key":"10.1016\/j.surg.2014.11.006_bib31","first-page":"1765","article-title":"Predictive factors of recurrence for patients with intrahepatic cholangiocarcinoma after hepatectomy","volume":"59","author":"Chen","year":"2012","journal-title":"Hepatogastroenterology"},{"key":"10.1016\/j.surg.2014.11.006_bib32","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1097\/SLA.0b013e3181e462e6","article-title":"Intrahepatic cholangiocarcinoma: primary liver resection and aggressive multimodal treatment of recurrence significantly prolong survival","volume":"252","author":"Ercolani","year":"2010","journal-title":"Ann Surg"},{"key":"10.1016\/j.surg.2014.11.006_bib33","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.surg.2012.12.005","article-title":"Recurrence after operative management of intrahepatic cholangiocarcinoma","volume":"153","author":"Hyder","year":"2013","journal-title":"Surgery"},{"key":"10.1016\/j.surg.2014.11.006_bib34","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1007\/s005340170039","article-title":"Recurrence after surgical resection of intrahepatic cholangiocarcinoma","volume":"8","author":"Yamamoto","year":"2001","journal-title":"J\u00a0Hepatobiliary Pancreat Surg"},{"key":"10.1016\/j.surg.2014.11.006_bib35","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1097\/00004728-200605000-00003","article-title":"Preoperative staging accuracy of multidetector row computed tomography for extrahepatic bile duct carcinoma","volume":"30","author":"Park","year":"2006","journal-title":"J\u00a0Comput Assist Tomogr"},{"key":"10.1016\/j.surg.2014.11.006_bib36","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1080\/13651820801992617","article-title":"Staging cholangiocarcinoma by imaging studies","volume":"10","author":"Vilgrain","year":"2008","journal-title":"HPB (Oxford)"},{"key":"10.1016\/j.surg.2014.11.006_bib37","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1097\/SLA.0b013e31822238d8","article-title":"Accurate staging for gallbladder cancer: implications for surgical therapy and pathological assessment","volume":"254","author":"Ito","year":"2011","journal-title":"Ann Surg"},{"key":"10.1016\/j.surg.2014.11.006_bib38","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1097\/SLA.0b013e3181d3d2b2","article-title":"Adequate lymph node assessment for extrahepatic bile duct adenocarcinoma","volume":"251","author":"Ito","year":"2010","journal-title":"Ann Surg"},{"key":"10.1016\/j.surg.2014.11.006_bib39","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1111\/liv.12364","article-title":"Staging, prognostic factors and adjuvant therapy of intrahepatic cholangiocarcinoma after curative resection","volume":"34","author":"Li","year":"2014","journal-title":"Liver Int"},{"key":"10.1016\/j.surg.2014.11.006_bib40","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1097\/01.coc.0000203742.22828.bb","article-title":"Combination chemotherapy with gemcitabine and cisplatin as first-line treatment for immunohistochemically proven cholangiocarcinoma","volume":"29","author":"Lee","year":"2006","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.surg.2014.11.006_bib41","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1097\/MOG.0b013e3280495451","article-title":"Cholangiocarcinoma: emerging approaches to a challenging cancer","volume":"23","author":"Patel","year":"2007","journal-title":"Curr Opin Gastroenterol"},{"key":"10.1016\/j.surg.2014.11.006_bib42","first-page":"783","article-title":"Phase II study of systemic gemcitabine chemotherapy for advanced unresectable hepatobiliary carcinomas","volume":"48","author":"Kubicka","year":"2001","journal-title":"Hepatogastroenterology"},{"key":"10.1016\/j.surg.2014.11.006_bib43","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1200\/JCO.2005.51.008","article-title":"Combining gemcitabine and capecitabine in patients with advanced biliary cancer: a phase II trial","volume":"23","author":"Knox","year":"2005","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.surg.2014.11.006_bib44","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s10147-013-0578-x","article-title":"A\u00a0single-center analysis of the survival benefits of adjuvant gemcitabine chemotherapy for biliary tract cancer","volume":"19","author":"Yamanaka","year":"2014","journal-title":"Int J Clin Oncol"},{"key":"10.1016\/j.surg.2014.11.006_bib45","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/1475-2867-13-99","article-title":"Prognosis of the intrahepatic cholangiocarcinoma after resection: hepatitis B virus infection and adjuvant chemotherapy are favorable prognosis factors","volume":"13","author":"Liu","year":"2013","journal-title":"Cancer Cell Int"}],"container-title":["Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039606014007235?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039606014007235?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,29]],"date-time":"2020-08-29T23:04:29Z","timestamp":1598742269000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039606014007235"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":45,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["S0039606014007235"],"URL":"https:\/\/doi.org\/10.1016\/j.surg.2014.11.006","relation":{},"ISSN":["0039-6060"],"issn-type":[{"value":"0039-6060","type":"print"}],"subject":[],"published":{"date-parts":[[2015,4]]}}}